In individuals who are deficient in CYP2D6, coadministration of modafinil with substrates of CYP2D6 which have ancillary routes of elimination through CYP2C19 (eg, tricyclic antidepressants and selective serotonin reuptake inhibitors) could produce elevated circulating amounts of these medication and involve dose adjustment (Robertson et al 2000; P